vaborbactam: Clinical Trials

2 trials of vaborbactam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow vaborbactam: new trials by email Literature Review of vaborbactam trials Research Report on vaborbactam

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
Meropenem-Vaborbactam, Piperacillin-Tazobactam, Levofloxacin - Urinary Tract Infection Complicated, Acute Pyelonephritis
Phase 3CompletedMelinta Therapeutics, Inc.5502014-11-202018-06-11
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
Vabomere, Best Available Therapy - Urinary Tract Infection Complicated, Acute Pyelonephritis
Phase 3CompletedRempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)772014-07-012019-03-04

Conditions studied

Bacteremia (1)  ·  Intraabdominal Infections (1)

Sponsors

Melinta Therapeutics, Inc. (1)  ·  Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) (1)

Countries

Brazil (2)  ·  Greece (2)  ·  Italy (2)  ·  United States (2)  ·  Argentina (1)  ·  Belarus (1)  ·  Bulgaria (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Israel (1)  ·  Peru (1)  ·  Poland (1)  ·  Romania (1)  ·  Slovakia (1)

Top investigators

Karen Fusaro (2)  ·  Keith Kaye (2)

Results publications

PMID 29486041, PMID 30270406, PMID 33565042